Welcome to the Fall 2024 Notable New Drugs Report
New treatments target relatively small, hard-to-treat patient populations with big drug spend.
This edition of the report showcases:
- A first-in-class treatment for both A and B hemophilia which can reduce the frequency of bleeding episodes.
- A new addition to standard breast cancer therapy with improved outcomes for people with HR-positive breast cancer.
- A new drug to treat a rare congenital heart disease can reduce the risk of death by 57%.
Related healthcare insights
Guide
Learn how identifying and addressing disparities in healthcare allows everyone to live their healthiest life.
Article
We know about the high prices for new drugs, but drug companies make most of their money from repeated small price increases on older drugs.
Report
Learn what’s at stake for pharmacy benefits sponsors as federal oversight changes and state legislative sessions begin.